Supported by:


This session evaluated how health care and frontline medicine will emerge from the COVID-19 pandemic. Being one of the sectors that was most affected by the crisis, healthcare was tackled from different points of view.

This session was composed of three conversations:


CONVERSATION 1 | Post-pandemic changes to healthcare and social welfare systems
16:00 – 18:00 CET

Speakers discussed how social welfare and health systems will be altered in the Post-COVID Era, as both a consequence and a response to the pandemic.

Speakers:

Ben Osborn, Regional President Hospital for International Developed Markets, Pfizer Hospital Business

Angela Spatharou, Senior Partner and EMEA Industry Leader, Healthcare & Life Sciences, IBM Consulting

Agnès Soucat, Director for Health Systems Governance and Financing, World Health Organization

Chris Wolff, Deputy Director, Global Delivery Program, Global Development Division, Bill and Melinda Gates Foundation

Moderated by Vikram Patel, Pershing Square Professor of Global Health and Wellcome Trust Principal Research Fellow, Harvard Medical School


CONVERSATION 2 | Risk assessment and prevention
16:00 – 18:00 CET

Medical risk assessment was examined, particularly with a focus on how the spread of infectious diseases can be predicted and halted. Can we conceive and design a physical environment that is better suited to disease prevention?

Speakers:

Pol VandenbrouckeChief Medical Officer, Pfizer’s Hospital Business Unite

Andrew J. Tatem, Director of WorldPop, University of Southampton

Jeffrey Shaman, Professor, Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University

John P.A. Ioannidis, C.F. Rehnborg Chair in Disease Prevention, Stanford University

Robert C. Gallo, The Homer & Martha Gudelsky Distinguished Professor in Medicine, University of Maryland School of Medicine; Co-Founder & Director, Institute of Human Virology

Tolullah Oni, Clinical Senior Research Associate, MRC Epidemiology Unit; Honorary Associate Professor, University of Cambridge

Wolfgang Philipp, Head of Unit, Public Health, Country Knowledge, Crisis Management Directorate of the European Commission

Moderated by Christopher Dye, Professor of Epidemiology, University of Oxford


CONVERSATION 3 | Technological breakthroughs driving medical advances
16:00 – 18:00 CET

This conversation navigated the technological breakthroughs that are driving medical advances, with participants discussing their vision for the future of healthcare and medicine.

Speakers:

Edward Abrahams, President, Personalized Medicine Coalition

Jennifer Miller, Founder, Bioethics International

Kenji Shibuya, Professor and Director of the Institute of Population Health, King’s College London

Laurie H. Glimcher, President and CEO, Dana-Farber Cancer Institute; Richard and Susan Smith Professor of Medicine, Harvard Medical School

Othman Laraki, Co-founder and CEO, Color

Peer M. Schatz, Managing Director, PS-Capital Management GmbH

Yoshiyuki Sankai, CEO and President, CYBERDYNE Inc.

Moderated by Carlos Bustamante, Principal Investigator, Stanford University School of Medicine